InvestorsHub Logo
Followers 8
Posts 842
Boards Moderated 0
Alias Born 01/27/2015

Re: None

Wednesday, 03/31/2021 10:25:54 PM

Wednesday, March 31, 2021 10:25:54 PM

Post# of 50362
INTRODUCING ARIA.

Addiction Recovery Institute of America (ARIA), is Ethema Health’s 174-bed addiction treatment facility located in West Palm Beach, Florida.The Property is large but unique, in that it has four separate self-contained treatment buildings with overnight beds, creating four separate smaller treatment centers in one location. This offers the Company tremendous flexibility with programming specialties in different buildings.


Operating 174 bed , not 51 as someone said,

https://t.co/6RmphQ4bde?amp=1

If someone thinks this isnt turning a profit they are crazy, $600,000 last November and December with out insurance and now we are fully licensed and able to run production on the rooms now if enough is coming through the door, what with their advertising and what not i Don t see what can be missed in my opinion.
On top of corvid clear signs all over it ,

Lets see some money with that and below,


Ethema Signs LOI on Acquisition of a majority Interest in Biohazard Health Services LLC

West Palm Beach, FL, June 16, 2020 – Ethema Health Corporation (OTCQB: GRST) (“Ethema” “GRST” or the “Company”), has signed an LOI to purchase a majority interest in Biohazard Health Services LLC of West Palm Beach, Florida (“Covid Clear”), or the (“Vendor”), is an environmental services company providing disinfecting, testing and training services to companies and institutions to provide their employees and customers with safe work and meeting spaces. The Vendor operates under its brand name Covid Clear and offers its customers a unique product through airborne delivery on a constant basis to keep spaces continuously disinfected. Covid Clear has a number of companies and institutions who have purchased services locally in Florida.

 

The LOI contemplates the purchase of the majority interest (51%) for $5,000,000.00 in a series of three tranches. The funds are to be retained by Covid Clear for working capital purposes. The first tranche buys 25% of Covid Clear for a payment of $250,000.00. The second and third tranches are dependent on Covid Clear reaching certain sales revenue thresholds. The second tranche buys an additional 15% for a payment of $1,750,000.00 and the third buys an additional 10% for a payment of $3,000,000.00. The initial closing is set for June 30, 2020. In addition to the majority interest in Covid Clear Ethema is buying the exclusive right to distribute the Covid Clear products in Canada on a royalty basis and an exclusive right to sell to the addiction treatment industry in the United States on a commission basis. Ethema will be issuing $100,000 of restricted Ethema common stock for these rights.

 


Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent GRST News